Taking azithromycin for as little as one day can trigger antibiotic resistance in the respiratory tract, according to a groundbreaking study by scientists at UC San Francisco. This research, a first-of-its-kind, examines the microbiome changes in hospitalized COVID-19 patients.
Azithromycin, a widely used antibiotic, is crucial for treating bacterial infections like strep throat, pneumonia, and certain sexually transmitted diseases. However, it is ineffective against viruses. Despite this, early in the pandemic, azithromycin was prescribed widely after initial studies suggested potential benefits. Subsequent randomized clinical trials disproved its efficacy against COVID-19, yet its use persisted.
“We’ve known for years that antibiotics don’t treat viral infections, but these results were striking,” said Dr. Chaz Langelier, MD, PhD. “That we could see resistance genes turning on in the respiratory tract within a day tells us the consequences of unnecessary antibiotic use aren’t theoretical or long-term. They’re immediate, measurable, and biologically real.”
Study Details and Findings
The findings, published on March 16 in Nature Microbiology, are part of a multi-center genomic study, partially funded by the National Institute of Allergy and Infectious Diseases (NIAID). Researchers tracked 1,164 COVID-19 patients hospitalized across more than 20 U.S. hospitals from May 2020 to March 2021, before the widespread availability of vaccines.
The study compared patients administered azithromycin to those who received no antibiotics and those given other antibiotics. The results showed that azithromycin altered the microbial composition in the upper airway, reducing some harmless bacteria while increasing potentially harmful ones. These changes persisted for over a week.
Implications for Antibiotic Use
This development follows a long-standing concern in the medical community about antibiotic misuse and its role in accelerating resistance. The misuse of antibiotics during the pandemic highlights the urgent need for more stringent guidelines and education on antibiotic prescriptions.
According to Dr. Langelier, the study’s implications are significant: “The rapid onset of resistance genes in the respiratory tract underscores the need for cautious antibiotic use, especially in viral infections where they offer no benefit.”
Future Research and Broader Context
Meanwhile, researchers plan to investigate whether other commonly used antibiotics, such as amoxicillin and ceftriaxone, exhibit similar effects in hospitalized patients. This could further illuminate the broader impact of antibiotic misuse beyond azithromycin.
The move represents a critical step in understanding and mitigating the risks associated with antibiotic resistance, a growing global health threat. According to the World Health Organization, antibiotic resistance is one of the top ten global public health threats facing humanity, with misuse and overuse of antibiotics being key drivers.
Expert Opinions and Historical Parallels
Experts have long warned about the dangers of antibiotic resistance. Dr. Abigail Glascock, PhD, a co-first author of the study, emphasized the historical parallels: “We’ve seen similar patterns with other antibiotics in the past. The lessons from this study should inform future practices to prevent a repeat of history.”
Historically, antibiotics have revolutionized medicine, saving countless lives. However, their overuse has led to the emergence of ‘superbugs’—bacteria that are resistant to multiple antibiotics, posing a severe challenge to modern medicine.
Conclusion and Next Steps
The study underscores the critical need for healthcare providers to adhere to evidence-based guidelines when prescribing antibiotics. As the research community continues to explore the effects of different antibiotics, it is essential to balance the benefits and risks to safeguard public health.
In conclusion, the findings from UC San Francisco offer a stark reminder of the immediate consequences of antibiotic misuse. As researchers delve deeper into this issue, the hope is to develop more effective strategies to combat antibiotic resistance and ensure the continued efficacy of these vital drugs.
